E

    Electromed Inc (ELMD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $27.82
    -1.78 (-6.01%)

    Market Cap: $234.00M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(25/35)
    Avg Surprise
    +88.51%
    Streak
    11 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.22
    Range$0.22 - $0.22
    1 analysts
    EPS RevisionsNo revisions (7d)
    1
    2
    30d
    EPS Estimate Drift
    90d ago$0.29+30.3%
    60d ago$0.29+30.3%
    30d ago$0.29+30.3%
    7d ago$0.29+30.3%
    Current$0.22
    Revenue Consensus
    $19M
    Range$19M - $20M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.36
    Range$0.36 - $0.36
    1 analysts
    EPS Revisions
    1
    0
    7d
    3
    0
    30d
    EPS Estimate Drift
    90d ago$0.39+9.3%
    60d ago$0.39+9.3%
    30d ago$0.39+9.3%
    7d ago$0.39+9.3%
    Current$0.36
    Revenue Consensus
    $21M
    Range$21M - $22M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.36---
    Sep 26EST
    		-$0.22---
    Jun 26
    Reported Aug 25
    		$0.39$0.32+21.88%Beat+56.0%
    Mar 26
    Reported May 12
    		$0.35$0.24+46.23%Beat+65.4%
    Dec 25
    Reported Feb 10
    		$0.32$0.26+23.08%Beat+45.5%
    Sep 25
    Reported Nov 12
    		$0.25$0.21+19.05%Beat+56.3%
    Jun 25
    Reported Aug 26
    		$0.25$0.22+13.64%Beat+25.0%
    Mar 25
    Reported May 13
    		$0.21$0.20+5.00%Beat+23.5%
    Dec 24
    Reported Feb 11
    		$0.22$0.18+22.22%Beat+15.8%
    Sep 24
    Reported Nov 12
    		$0.16$0.03+433.33%Beat+700.0%
    Jun 24
    Reported Aug 27
    		$0.20$0.14+42.86%Beat+66.7%
    Mar 24
    Reported May 7
    		$0.17$0.13+30.77%Beat+41.7%
    Dec 23
    Reported Feb 13
    		$0.19$0.10+90.00%Beat+72.7%
    Sep 23
    Reported Nov 7
    		$0.02N/A-80.00%Miss+100.0%
    Jun 23
    Reported Aug 22
    		$0.12$0.13-7.69%Miss+200.0%
    Mar 23
    Reported May 9
    		$0.12$0.10+20.00%Beat+71.4%
    Dec 22
    Reported Feb 14
    		$0.11$0.02+450.00%Beat+10.0%
    Sep 22
    Reported Nov 8
    		$0.01N/A-75.00%Miss-80.0%
    Jun 22
    Reported Aug 23
    		$0.04$0.08-50.00%Miss+0.0%
    Mar 22
    Reported May 10
    		$0.07$0.05+40.00%Beat+133.3%
    Dec 21
    Reported Feb 8
    		$0.10$0.07+42.86%Beat-23.1%
    Sep 21
    Reported Nov 9
    		$0.05$0.06-16.67%Miss-16.7%
    Jun 21
    Reported Aug 24
    		$0.04$0.06-33.33%Miss-71.4%
    Mar 21
    Reported May 11
    		$0.03$0.06-50.00%Miss-57.1%
    Dec 20
    Reported Feb 9
    		$0.13$0.04+225.00%Beat-7.1%
    Sep 20
    Reported Nov 10
    		$0.06$-0.05+220.00%Beat-50.0%
    Jun 20
    Reported Aug 25
    		$0.14$-0.15+193.33%Beat+7.7%
    Mar 20
    Reported May 12
    		$0.07$0.06+16.67%Beat+75.0%
    Dec 19
    Reported Feb 11
    		$0.14$0.04+250.00%Beat+250.0%
    Sep 19
    Reported Nov 12
    		$0.12$0.01+1100.00%Beat+500.0%
    Jun 19
    Reported Aug 27
    		$0.13$0.13+0.00%Beat+0.0%
    Mar 19
    Reported May 7
    		$0.04N/AN/ABeat+0.0%
    Dec 18
    Reported Feb 12
    		$0.04N/AN/ABeat-31.6%
    Sep 18
    Reported Nov 13
    		$0.02N/AN/ABeat+100.0%
    Jun 18
    Reported Sep 25
    		$0.13$0.07+85.71%Beat+18.2%
    Mar 18
    Reported May 8
    		$0.04$0.07-42.86%Miss-50.0%
    Dec 17
    Reported Feb 13
    		$0.06$0.03+95.00%Beat+17.0%
    Sep 17
    Reported Nov 7
    		$0.01N/A-66.67%Miss-50.0%
    Jun 17
    Reported Sep 5
    		$0.11$0.00N/ABeat-
    Mar 17
    Reported May 15
    		$0.08$0.00N/ABeat-
    Dec 16
    Reported Feb 7
    		$0.05$0.03+66.67%Beat-
    Sep 16
    Reported Nov 8
    		$0.02$0.03-33.33%Miss-

    Key Metrics

    Valuation
    P/E Ratio21.28EV/EBITDA15.49x
    Price/FCF27.15xFCF Yield3.68%
    Profitability
    Profit Margin15.30%Operating Margin19.70%
    ROE23.30%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio4.91xQuick Ratio4.59x
    Trading Statistics
    Beta0.51Avg Volume95.08K
    52-Week High$47.4052-Week Low$23.01

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$36.07
    SMA 20$39.02
    SMA 50$40.73
    SMA 200$31.36
    EMA 10$34.44
    EMA 20$37.19
    EMA 50$38.53
    EMA 200$32.88

    MACD

    Line: -2.71Signal: -1.21Hist: -1.51

    ADX

    ADX: 26.2+DI: 10.2-DI: 43.8

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down100.0
    PSAR$39.29

    Bollinger Bands

    Upper Band$48.75
    Lower Band$29.29
    %B Position4986%(Upper)
    Band Width-0.08

    RSI (14-Day)

    Oversold
    17.6

    Momentum Oscillators

    Stoch %K2.1
    Stoch %D4.0
    Williams %R-99.9
    ROC (10d)-30.8%
    Momentum-12.41
    CCI (20d)-213.8
    MFI (14d)20.1

    Volatility Measures

    ATR (14d)$2.12(7.6%)
    StdDev (20d)4.86
    Hist Vol73.9%(High)

    Volume Flow

    VWAP$28.33
    OBV190.7K
    AD Line474.8K
    CMF (20d)-0.418

    Volume Metrics

    Avg Vol (20d)96.0K
    Vol Ratio1.9x(High)
    VWMA (20d)$36.08

    Pivot Points

    R3$32.26
    R2$31.46
    R1$30.53
    Pivot Point$29.73
    S1$28.80
    S2$28.00
    S3$27.07

    Advanced Oscillators

    TSI-40.83
    Ultimate Osc21.0
    KST-122.03

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$18.57M$18.90M$16.89M$17.39M$15.68M$16.25M$14.67M$14.83M$13.87M$13.69M$12.32M$13.61M
    Cost of Revenue$3.93M$4.08M$3.69M$3.77M$3.46M$3.63M$3.18M$3.53M$3.49M$3.14M$2.83M$3.16M
    Gross Profit$14.64M$14.82M$13.20M$13.62M$12.23M$12.63M$11.49M$11.30M$10.38M$10.54M$9.50M$10.45M
    Operating Expenses$10.88M$11.20M$10.53M$10.58M$10.09M$10.09M$9.55M$8.97M$8.54M$8.28M$9.36M$8.96M
    R&D$361,000$384,000$241,000$302,000$277,000$251,000$166,000$176,000$167,000$107,000$206,000$298,000
    SG&A$10.52M$10.81M$10.29M$10.28M$9.81M$9.83M$9.39M$8.79M$8.37M$8.18M$9.15M$8.66M
    Operating Income$3.77M$3.62M$2.67M$3.04M$2.14M$2.54M$1.94M$2.33M$1.84M$2.26M$142,000$1.49M
    Interest Income$100,000$109,000$134,000$0$142,000$152,000$195,000$0$120,000$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$-96,000$-77,000$-41,000
    Income Before Tax$3.87M$3.73M$2.80M$3.17M$2.28M$2.69M$2.13M$2.50M$1.96M$2.36M$219,000$1.53M
    Income Tax Expense$863,000$968,000$668,000$971,000$391,000$726,000$659,000$669,000$468,000$685,000$64,000$502,000
    Net Income$3.00M$2.76M$2.14M$2.20M$1.89M$1.97M$1.47M$1.83M$1.49M$1.67M$155,000$1.03M
    EBITDA$4.05M$3.88M$2.93M$3.44M$2.42M$2.81M$2.16M$2.54M$2.05M$2.47M$356,000$1.69M
    EBIT$3.77M$3.62M$2.67M$3.04M$2.14M$2.54M$1.94M$2.33M$1.84M$2.26M$142,000$1.49M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ELMD

    News

    Electromed Q4 Results: EPS beats estimate, sales rise 11.6% YoY

    Electromed (AMEX: ELMD) reported record Q4 EPS of $0.39, exceeding estimates by 21.88%, with quarterly sales rising 11.6% year-over-year to $19.4 million. For the full fiscal year 2026, revenue grew 15.3% to $73.0 million, and diluted EPS reached $1.30. Additionally, CEO Jim Cunniff announced his planned retirement for April 2027, with a succession plan underway.

    scanx.trade•8/26/26•
    Bullish

    Transcript : Electromed, Inc., Q4 2026 Earnings Call, Aug 25, 2026

    This article provides a transcript of Electromed, Inc.'s Q4 2026 Earnings Call held on August 25, 2026. It includes a brief summary noting Electromed's fiscal Q4 earnings and revenue rise, alongside the announcement of the CEO's retirement. The full transcript is reserved for subscribers, offering detailed insights into the company's financial performance and future outlook.

    www.marketscreener.com•8/26/26•
    Somewhat-Bullish

    Electromed Q4 2026 Earnings Call: Complete Transcript

    Electromed Inc. reported record Q4 2026 net revenue of $19.4 million, a 12% increase year-over-year, and operating income growth of 26% to $3.8 million. The company expanded its direct sales force and announced CEO Jim Cunniff's planned retirement in April 2027, with a succession plan in place. Electromed achieved 78.5% gross margin for fiscal 2026 and 15.3% annual revenue growth to $73 million, driven by its core home care channel and strategic initiatives like the "Triple Down on Bronchiectasis" campaign.

    Benzinga•8/25/26•
    Bullish

    Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates

    Electromed, Inc. (ELMD) reported Q4 earnings of $0.39 per share, exceeding the Zacks Consensus Estimate of $0.32, marking a 21.88% surprise. The company's revenues for the quarter were $19.42 million, slightly missing the consensus estimate. Electromed's stock has seen a significant increase of 38.4% year-to-date, outperforming the S&P 500, and currently holds a Zacks Rank #3 (Hold).

    Yahoo Finance•8/25/26•
    Bullish

    Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results

    Electromed, Inc. (NYSE American: ELMD) reported record financial results for both the fourth quarter and full fiscal year ended June 30, 2026. The company saw significant growth in net revenue and operating income, driven by strong homecare revenue and expanded operating leverage. Electromed also highlighted its robust balance sheet, strategic investments, and ongoing efforts to address the bronchiectasis market.

    Business Wire•8/25/26•
    Bullish

    Frequently Asked Questions About ELMD

    Does ELMD pay dividends?
    Electromed Inc (ELMD) does not currently pay a regular dividend.
    What is ELMD's P/E ratio?
    Electromed Inc has a price-to-earnings (P/E) ratio of 21.28.
    What is ELMD's market cap?
    Electromed Inc (ELMD) has a market capitalization of $234.00M with a current stock price of $27.82.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In